Chartwell Investment Partners LLC trimmed its position in shares of LHC Group, Inc. (NASDAQ:LHCG) by 1.7% during the fourth quarter, HoldingsChannel reports. The firm owned 304,101 shares of the health services provider’s stock after selling 5,218 shares during the quarter. LHC Group comprises 1.0% of Chartwell Investment Partners LLC’s portfolio, making the stock its 7th largest holding. Chartwell Investment Partners LLC’s holdings in LHC Group were worth $28,549,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in LHCG. Janney Montgomery Scott LLC increased its stake in LHC Group by 1,171.2% in the 4th quarter. Janney Montgomery Scott LLC now owns 31,959 shares of the health services provider’s stock valued at $3,000,000 after buying an additional 29,445 shares during the last quarter. State Board of Administration of Florida Retirement System increased its stake in LHC Group by 4.7% in the 4th quarter. State Board of Administration of Florida Retirement System now owns 34,602 shares of the health services provider’s stock valued at $3,248,000 after buying an additional 1,557 shares during the last quarter. SG Americas Securities LLC increased its stake in LHC Group by 1,821.7% in the 4th quarter. SG Americas Securities LLC now owns 37,358 shares of the health services provider’s stock valued at $3,507,000 after buying an additional 35,414 shares during the last quarter. Rhumbline Advisers increased its stake in LHC Group by 21.9% in the 4th quarter. Rhumbline Advisers now owns 84,102 shares of the health services provider’s stock valued at $7,895,000 after buying an additional 15,125 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its stake in LHC Group by 4,198.2% in the 4th quarter. Advisors Asset Management Inc. now owns 11,906 shares of the health services provider’s stock valued at $1,118,000 after buying an additional 11,629 shares during the last quarter. 87.03% of the stock is currently owned by institutional investors.

LHCG has been the topic of several recent research reports. Zacks Investment Research upgraded shares of LHC Group from a “hold” rating to a “buy” rating and set a $106.00 price target on the stock in a research note on Tuesday, November 6th. Craig Hallum lowered shares of LHC Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $99.00 to $92.00 in a research note on Friday, October 26th. William Blair reiterated a “buy” rating on shares of LHC Group in a research note on Thursday, November 1st. Barclays initiated coverage on shares of LHC Group in a research note on Friday, December 14th. They issued an “equal weight” rating and a $105.00 price target on the stock. Finally, UBS Group initiated coverage on shares of LHC Group in a research note on Thursday, November 15th. They issued a “buy” rating and a $109.00 price target on the stock. Four investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. LHC Group presently has an average rating of “Buy” and a consensus target price of $105.77.

Shares of LHCG opened at $110.92 on Tuesday. LHC Group, Inc. has a one year low of $58.65 and a one year high of $110.99. The stock has a market capitalization of $3.34 billion, a PE ratio of 35.07, a PEG ratio of 1.51 and a beta of 0.89. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17.

In other news, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $103.40, for a total value of $7,755,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Keith G. Myers sold 6,790 shares of LHC Group stock in a transaction dated Monday, January 7th. The shares were sold at an average price of $95.01, for a total transaction of $645,117.90. Following the completion of the transaction, the chief executive officer now directly owns 155,475 shares of the company’s stock, valued at approximately $14,771,679.75. The disclosure for this sale can be found here. In the last three months, insiders sold 241,821 shares of company stock valued at $24,422,790. Insiders own 6.80% of the company’s stock.

WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.watchlistnews.com/chartwell-investment-partners-llc-trims-stake-in-lhc-group-inc-lhcg/2796852.html.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Article: 52-Week High/Low Prices For Stock Selection

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.